Breast cancer symposium in Drammen

Scandic Hotel Ambassadeur Drammen, November 11-12, 2019

Organized by: Vestre Viken Hospital, the Cancer Registry of Norway and National Network for Breast Cancer Research

There are three main topics for the event and international and national speakers are invited:

MRI in diagnostics and treatment for breast cancer

Multifocality in diagnostics and treatment for breast cancer

Low grade tumors; overdiagnosed and/or overtreated?

Use the link to register (click here)

Registration before September 30.

Programme 

Monday November 11th

10.00 -10.15     Welcome

Session I: MR diagnostic and treatment of breast cancer

Chair: Tone Hovda, Vestre Viken Hospital Trust, Norway

10.15 –  10.25  Use of breast MRI in Norway, Tone Hovda, Vestre Viken Hospital Trust, Norway
10.25 – 11:05  Breast MRI or not? Ritse Mann, Radboud University Medical Centre, Nijmegen, The Netherlands
11:05 – 11.40                                          Use of MRI and spectroscopy in identification of the functional and metabolic changes in cancer disease, Tone Bathen, Norwegian University of Science and Technology (NTNU), Norway
11.40 – 12:00 Coffee
12:00 – 12.30 MRI for computer simulations of breast cancer treatment, Alvaro Køhn-Luque, University of Oslo, Norway
12.30 – 13.00 Discussion
13.00 – 14:00 Lunch

Session II: Multifocality in breast diagnostic and treatment

Chair: Solveig Hofvind, Vestre Viken Hospital Trust, Norway

14:00 – 14:10 Status of multifocal breast tumors in Norway today, Helle Skjerven, Vestre Viken Hospital Trust, Norway
14:10 – 14.50 Multifocality in breast diagnostics and treatment in a radiologic and pathologic perspective – Tibor Tot, Uppsala University, Sweden
14:50 – 15.15 Coffee
15:15 – 16:00                         Multifocality in breast diagnostics and treatment in a radiologic and pathologic perspective – Tibor Tot, Uppsala University, Sweden
16:00 – 16:40 Multifocality Breast Cancer: opportunities to safely spare the breast, Emiel Rutgers, Netherlands Cancer Institute, Amsterdam, The Netherlands
16.40 – 17:00 Discussion
19.00 Dinner

Tuesday November 12th

Session III: Low grade tumors, overdiagnosed and/or overtreated?

Chair: Bjørn Naume, Oslo University Hospital, Norway 

09.00 – 09.10 DCIS in Norway, Solveig Hofvind, Cancer Registry of Norway, Norway
09.10 – 09.45 From DCIS to infiltrating cancer, Torill Sauer, Akershus University Hospital, Norway
09.45 – 10:20               Molecular profiles of DCIS from a clinical point of view, Therese Sørlie, Oslo University Hospital, Norway
10.20 – 10.45 Coffee
10.45 – 11.30 DCIS Treatment challenges in Europe – Matthew Wallis, Cambridge University, United Kingdom
11.30 – 12.00 DCIS and radiation treatment, can it be avoided? Ingvil Mjaaland, Stavanger University Hospital, Norway,
12.00 – 12.30 Discussion
12.30 – 13.30 Lunch

Session IV: Case presentations
Interesting selected cases form the tumor board will be presented, 15 min per case. Project presentation, 10 min per project.

Chair: Kristine K. Sahlberg, Vestre Viken Hospital Trust, Norway

13.15 – 14.15     Case presentation (3 cases)
14.15 – 14.35 Coffee
14.35 – 15.40 Project presentations (4 presentations)

  • The EMIT and OPTIMA studies – Bjørn Naume, Oslo University Hospital, Norway
  • The LORD Study – Margit Riis, Oslo University Hospital, Norway
  • Using clinical cancer registry data for estimation of quality indicators: Result from the Norwegian breast cancer registry  Olaf Johan Hartmann-Johnsen, Østfold Hospital Trust, Norway
  • The TYDE study – Heinrich Backmann, Norland Hospital Trust, Norway,
  • Quality-of-life effects of screening mammography in Norway- Pål Suhrke, Vestfold Hospital Trust, Norway
15.40 – 16.00 Closing remarks